Porton Pharma Solutions is an API manufacturer based in China. It holds 18 active US drug master files and 2 valid CEPs across a filed portfolio of 19 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 29 March 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Chongqing, China | Not on file |
| Changshou, China | Not on file |
| China, China | 3006625990 |
| Molecule | Regulators | Docs |
|---|---|---|
| Nicotine | EDQM, US FDA | 2 |
| Abemaciclib | US FDA | 1 |
| Alectinib | US FDA | 1 |
| Baloxavir Marboxil | US FDA | 1 |
| Dapagliflozin | US FDA | 1 |
| Darunavir | US FDA | 1 |
| Dexrazoxane | US FDA | 1 |
| Hydroxychloroquine | EDQM | 1 |
| Isavuconazonium | US FDA | 1 |
| Mefloquine | US FDA | 1 |
| Niraparib | US FDA | 1 |
| Phloroglucinol | US FDA | 1 |
| Relugolix | US FDA | 1 |
| Rimegepant | US FDA | 1 |
| Salmeterol | US FDA | 1 |
| Tiopronin | US FDA | 1 |
| Venetoclax | US FDA | 1 |
| Vibegron | US FDA | 1 |
| Vonoprazan | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Choose your molecules and target markets. Porton Pharma Solutions comes back tiered against every other supplier able to file there.
Start for free